Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528014) titled 'ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1' on April 7.
Study Type: Observational [Patient Registry]
Primary Sponsor: Salma Health, Inc.
Condition:
Depressed Mood
Recruitment Status: Recruiting
Date of First Enrollment: March 25, 2026
Target Sample Size: 5000
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07528014
Disclaimer: Curated by HT Syndication....